Newman Katherine Quinn, Castles Charles Guy
Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.
Medical University of South Carolina, Charleston, SC, USA.
Case Rep Rheumatol. 2023 Jul 5;2023:7353644. doi: 10.1155/2023/7353644. eCollection 2023.
Minocycline, a tetracycline antibiotic, is commonly used to treat rosacea and acne vulgaris. A rare adverse reaction of minocycline use is the development of drug-induced lupus. Fortunately, most patients recover from minocycline-induced lupus (MIL) after the drug is discontinued. However, many patients, after recovering from MIL, may desire further treatment for their acne and may consider doxycycline, a close relative of minocycline. Though no cases of doxycycline-induced lupus have been reported, there is little guidance in the medical literature as to whether doxycycline poses a particular risk to patients who have recovered from MIL. We report the long-term follow-up of a patient who recovered from MIL (the diagnosis satisfying clinical and laboratory criteria) and was treated for 8 years with various forms of doxycycline without any untoward effects, suggesting that, at least in some cases, doxycycline can be used safely following MIL.
米诺环素是一种四环素类抗生素,常用于治疗玫瑰痤疮和寻常痤疮。使用米诺环素的一种罕见不良反应是药物性狼疮的发生。幸运的是,大多数患者在停用该药物后可从米诺环素诱导的狼疮(MIL)中康复。然而,许多患者在从MIL康复后,可能希望进一步治疗痤疮,并可能考虑使用多西环素,它是米诺环素的近亲。虽然尚未有关于多西环素诱导狼疮的病例报告,但医学文献中对于多西环素对从MIL康复的患者是否构成特殊风险几乎没有指导意见。我们报告了一名从MIL康复的患者(诊断符合临床和实验室标准)的长期随访情况,该患者接受了8年的各种形式多西环素治疗,未出现任何不良影响,这表明至少在某些情况下,MIL后可安全使用多西环素。